(Q28076119)

G V Ramesh Prasad

series ordinal

2

1 reference

language of work or name

1 reference

24 March 2016

1 reference

World journal of transplantation

published in

1 reference

volume

6

1 reference

issue

1

1 reference

page(s)

125-34

1 reference

Dyslipidemia and its therapeutic challenges in renal transplantation

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Analysis of adult 20-year survivors after liver transplantation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

An observational study of ezetimibe in cardiac transplant recipients receiving calcineurin inhibitors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Long-term medical management of the liver transplant recipient: what the primary care physician needs to know

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Progression of coronary artery calcification in renal transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

South Asian ethnicity as a risk factor for major adverse cardiovascular events after renal transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Effects of combination lipid therapy in type 2 diabetes mellitus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Low levels of high-density lipoprotein cholesterol: an independent risk factor for late adverse cardiovascular events in renal transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Reducing the risks of cardiovascular disease in liver allograft recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Treatment of hyperlipidemia in cardiac transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Strategies for minimizing hyperlipidemia after cardiac transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Deterioration in renal function associated with fibrate therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Hyperlipidemia as a risk factor of renal allograft function impairment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Atherosclerosis and lipid disorders after renal transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Hyperlipidaemia following renal transplantation. A study of the prevalence, 'natural history' and dietary treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Patient survival after renal transplantation III: the effects of statins

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Rethinking chronic allograft nephropathy: the concept of accelerated senescence.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Treatment of hyperlipidemia in renal transplant recipients

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Hyperlipidemia in solid organ transplantation.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Plasma lipids following renal transplantation

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Lipid and lipoprotein abnormalities in children on hemodialysis and after renal transplantation

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Weight change and serum lipoproteins in recipients of renal allografts

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantation

2 June 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Impact of lung transplantation on serum lipids in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Effect of ABCB1 genotype on pre- and post-cardiac transplantation plasma lipid concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Higher tacrolimus blood concentration is related to hyperlipidemia in living donor liver transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Effect of apolipoprotein E gene polymorphism on serum lipid level before and after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Cumulative risk of cardiovascular events after orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Prediction of cardiac complications after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Renal transplant dysfunction—importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.5500%2FWJT.V6.I1.125

Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.3. Cardiovascular risks. Hyperlipidaemia

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4801788

Enzymes of lipid synthesis in the liver of the cortisone-treated rat

27 November 2018

1 reference

12 December 2020

Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium

1 reference

12 December 2020

Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients

1 reference

12 December 2020

Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A

1 reference

12 December 2020

Plasma exchange for severe hypertriglyceridemia-induced pancreatitis in an orthotopic heart transplant recipient

1 reference

12 December 2020

Lipoprotein-apolipoprotein changes in renal transplant recipients: a 2-year follow-up

1 reference

12 December 2020

Oxidation of low density lipoproteins from patients with renal failure or renal transplants

1 reference

12 December 2020

Prevalence of hyperlipidemia in heart transplant recipients

1 reference

12 December 2020

Increased low density lipoprotein oxidation in stable kidney transplant recipients

1 reference

12 December 2020

Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?

1 reference

12 December 2020

Lipoprotein lipid abnormalities in healthy renal transplant recipients: persistence of low HDL2 cholesterol

1 reference

12 December 2020

Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression

1 reference

12 December 2020

Impact of lung transplantation on serum lipids in COPD

1 reference

12 December 2020

Cardiovascular morbidity and risk factors in renal transplant patients

1 reference

12 December 2020

Follow-Up of Lipid and Apoprotein Levels in Renal Transplant Recipients

1 reference

12 December 2020

Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants

1 reference

12 December 2020

Cholesterol as an independent predictor of outcome after renal transplantation

1 reference

12 December 2020

Lipid relation ships in dialysis and renal transplant patients

1 reference

12 December 2020

Cyclosporine, low-density lipoprotein, and cholesterol

1 reference

12 December 2020

Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection

1 reference

12 December 2020

The apo A-I gene promoter region polymorphism determines the severity of hyperlipidemia after heart transplantation

1 reference

12 December 2020

Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients

1 reference

12 December 2020

Persistent hyperlipidemia in renal transplant patients

1 reference

12 December 2020